http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109847008-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63705d6c7feab3cf52042dc291f59568 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197 |
| filingDate | 2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9054b0133794e379dfde9190224dff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7cbeb75cf72b761c979e2de0056bfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ee786e72d0e48fceed001c84ae6e6d |
| publicationDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109847008-A |
| titleOfInvention | A slow-release pharmaceutical composition for treating anxiety disorder and preparation method thereof |
| abstract | The invention discloses a sustained-release pharmaceutical composition for treating anxiety disorder, which is characterized in that it is prepared from the following raw materials in parts by weight: 45-55 parts of tandospirone citrate, 4-aminobutyric acid alginic acid modified together 10-15 parts of sexual copolymer, 5-10 parts of filler, 3-5 parts of porogen, 1-3 parts of lubricant, 3-5 parts of Chinese herbal medicine extract, 5-10 parts of water; Allyl β-D-glucopyranoside, sweet glucoside and 1-vinyl-3-butylimidazolium chloride are prepared by free radical copolymerization. The sustained-release pharmaceutical composition for treating anxiety disorder disclosed by the invention has good sustained-release effect, good effect for treating anxiety disorder, high efficiency, stable curative effect, long-lasting effect, convenient administration, simple preparation process, abundant raw material sources, and good medication compliance. It has few toxic and side effects, is safe to use, and is suitable for clinical use. |
| priorityDate | 2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.